700
Views
5
CrossRef citations to date
0
Altmetric
REVIEW

Bibliometric Analysis of Research Themes and Trends of the Co-Occurrence of Autism and ADHD

ORCID Icon, ORCID Icon, , , &
Pages 985-1002 | Received 14 Jan 2023, Accepted 05 Apr 2023, Published online: 24 Apr 2023

References

  • Johnson MH, Gliga T, Jones E, et al. Annual research review: infant development, autism, and ADHD – early pathways to emerging disorders. J Child Psychol Psychiatry. 2015;56(3):228–247. doi:10.1111/jcpp.12328
  • Dellapiazza F, Audras-Torrent L, Michelon C, et al. Clinical characteristics of children with ASD and comorbid ADHD: association with social impairment and externalizing and internalizing behaviours. Res Dev Disabil. 2021;113:103930. doi:10.1016/j.ridd.2021.103930
  • Lai M-C, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896–910. doi:10.1016/S0140-6736(13)61539-1
  • Childress AC, Stark JG. Diagnosis and treatment of attention-deficit/hyperactivity disorder in preschool-aged children. J Child Adolesc Psychopharmacol. 2018;28(9):606–614. doi:10.1089/cap.2018.0057
  • Antshel KM, Russo N. Autism spectrum disorders and ADHD: overlapping phenomenology, diagnostic issues, and treatment considerations. Curr Psychiatry Rep. 2019;21(5):34. doi:10.1007/s11920-019-1020-5
  • Doernberg E, Hollander E. Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11. CNS Spectr. 2016;21(4):295–299. doi:10.1017/S1092852916000262
  • Davis NO, Kollins SH. Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder. Neurotherapeutics. 2012;9(3):518–530. doi:10.1007/s13311-012-0126-9
  • Mayes SD, Waxmonsky JG, Baweja R, et al. Symptom scores and medication treatment patterns in children with ADHD versus autism. Psychiatry Res. 2020;288:112937. doi:10.1016/j.psychres.2020.112937
  • Zablotsky B, Bramlett MD, Blumberg SJ. The co-occurrence of autism spectrum disorder in children with ADHD. J Atten Disord. 2020;24(1):94–103. doi:10.1177/1087054717713638
  • Panagiotidi M, Overton PG, Stafford T. Co-Occurrence of ASD and ADHD traits in an adult population. J Atten Disord. 2019;23(12):1407–1415. doi:10.1177/1087054717720720
  • May T, Adesina I, McGillivray J, et al. Sex differences in neurodevelopmental disorders. Curr Opin Neurol. 2019;32(4):622–626. doi:10.1097/WCO.0000000000000714
  • Polderman TJ, Hoekstra RA, Posthuma D, et al. The co-occurrence of autistic and ADHD dimensions in adults: an etiological study in 17,770 twins. Transl Psychiatry. 2014;4:e435. doi:10.1038/tp.2014.84
  • Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A. 2004;101(Suppl1):5303–5310. doi:10.1073/pnas.0307513100
  • van Eck NJ, Waltman L. Software survey: vOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–538. doi:10.1007/s11192-009-0146-3
  • Lopez-Munoz F, Tracy DK, Povedano-Montero FJ, et al. Trends in the scientific literature on atypical antipsychotic drugs in the United Kingdom: a bibliometric study. Ther Adv Psychopharmacol. 2019;9:2045125318820207. doi:10.1177/2045125318820207
  • Xu D, Wang YL, Wang KT, et al. A scientometrics analysis and visualization of depressive disorder. Curr Neuropharmacol. 2021;19(6):766–786. doi:10.2174/1570159X18666200905151333
  • Konst MJ, Matson JL, Goldin R, et al. How does ASD symptomology correlate with ADHD presentations? Res Dev Disabil. 2014;35(9):2252–2259. doi:10.1016/j.ridd.2014.05.017
  • Antshel KM, Zhang-James Y, Wagner KE, et al. An update on the comorbidity of ADHD and ASD: a focus on clinical management. Expert Rev Neurother. 2016;16(3):279–293. doi:10.1586/14737175.2016.1146591
  • Kao HSR. Shufa: Chinese calligraphic handwriting (CCH) for health and behavioural therapy. Int J Psychol. 2006;41(4):282–286. doi:10.1080/00207590544000059
  • Druetz T. Integrated primary health care in low- and middle-income countries: a double challenge. BMC Med Ethics. 2018;19(Suppl 1):48. doi:10.1186/s12910-018-0288-z
  • Carpenter KLH, Davis NO, Spanos M, et al. Adaptive behavior in young autistic children: associations with irritability and ADHD symptoms. J Autism Dev Disord. 2022. doi:10.1007/s10803-022-05753-2
  • Sandin S, Lichtenstein P, Kuja-Halkola R, et al. The familial risk of autism. JAMA. 2014;311:17. doi:10.1001/jama.2014.4144
  • Lichtenstein P, Olausson PO, Källén AJ. Twin births to mothers who are twins: a registry based study. BMJ. 1996;312(7035):879–881. doi:10.1136/bmj.312.7035.879
  • Lichtenstein P, De Faire U, Floderus B, et al. The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med. 2002;252(3):184–205. doi:10.1046/j.1365-2796.2002.01032.x
  • Lee PH, Anttila V, Won H, et al. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell. 2019;179(7):1469–1482.e11. doi:10.1016/j.cell.2019.11.020
  • Jami ES, Hammerschlag AR, Ip HF, et al. Genome-wide association meta-analysis of childhood and adolescent internalizing symptoms. J Am Acad Child Adolesc Psychiatry. 2022;61(7):934–945. doi:10.1016/j.jaac.2021.11.035
  • Demontis D, Walters RK, Martin J, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2018;51(1):63–75. doi:10.1038/s41588-018-0269-7
  • Grove J, Ripke S, Als TD, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51(3):431–444. doi:10.1038/s41588-019-0344-8
  • Maenner MJ, Shaw KA, Bakian AV, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2018. MMWR Surveill Summ. 2021;70(11):1–16. doi:10.15585/mmwr.ss7011a1
  • Cooper M, Martin J, Langley K, et al. Autistic traits in children with ADHD index clinical and cognitive problems. Eur Child Adolesc Psychiatry. 2014;23(1):23–34. doi:10.1007/s00787-013-0398-6
  • Baranova A, Wang J, Cao H, et al. Shared genetics between autism spectrum disorder and attention-deficit/hyperactivity disorder and their association with extraversion. Psychiatry Res. 2022;314:114679. doi:10.1016/j.psychres.2022.114679
  • Staal WG, de Krom M, de Jonge MV. Brief report: the dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrum disorder (ASD). J Autism Dev Disord. 2012;42(5):885–888. doi:10.1007/s10803-011-1312-z
  • Seigneur E, Wang J, Dai J, et al. Cerebellin-2 regulates a serotonergic dorsal raphe circuit that controls compulsive behaviors. Mol Psychiatry. 2021;26(12):7509–7521. doi:10.1038/s41380-021-01187-x
  • Zhao Y, Yang L, Gong G, et al. Identify aberrant white matter microstructure in ASD, ADHD and other neurodevelopmental disorders: a meta-analysis of diffusion tensor imaging studies. Prog Neuropsychopharmacol Biol Psychiatry. 2022;113:110477. doi:10.1016/j.pnpbp.2021.110477
  • Lim L, Chantiluke K, Cubillo AI, et al. Disorder-specific grey matter deficits in attention deficit hyperactivity disorder relative to autism spectrum disorder. Psychol Med. 2015;45(5):965–976. doi:10.1017/S0033291714001974
  • Hoogman M, van Rooij D, Klein M, et al. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: the ENIGMA adventure. Hum Brain Mapp. 2022;43(1):37–55. doi:10.1002/hbm.25029
  • Hours C, Recasens C, Baleyte JM. ASD and ADHD comorbidity: what are we talking about? Front Psychiatry. 2022;13:837424. doi:10.3389/fpsyt.2022.837424
  • Harkins CM, Handen BL, Mazurek MO. The Impact of the Comorbidity of ASD and ADHD on Social Impairment. J Autism Dev Disord. 2022;52(6):2512–2522. doi:10.1007/s10803-021-05150-1
  • Uddin LQ, Dajani DR, Voorhies W, et al. Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder. Transl Psychiatry. 2017;7(8):e1218. doi:10.1038/tp.2017.164
  • Healy-Stoffel M, Levant B. N-3 (Omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders. CNS Neurol Disord Drug Targets. 2018;17(3):216–232. doi:10.2174/1871527317666180412153612
  • James S, Montgomery P, Williams K, Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2011;11:CD007992. doi:10.1002/14651858.CD007992.pub2
  • Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50(10):991–1000. doi:10.1016/j.jaac.2011.06.008
  • Shaaban SY, El Gendy YG, Mehanna NS, et al. The role of probiotics in children with autism spectrum disorder: a prospective, open-label study. Nutr Neurosci. 2018;21(9):676–681. doi:10.1080/1028415X.2017.1347746
  • Pärtty A, Kalliomäki M, Wacklin P, et al. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res. 2015;77(6):823–828. doi:10.1038/pr.2015.51
  • Isolauri E, Kalliomäki M, Laitinen K, et al. Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease. Curr Pharm Des. 2008;14(14):1368–1375. doi:10.2174/138161208784480207